The disclosure provides compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their uses in inhibiting β-amyloid peptide (β-AP) production.
[EN] 2-ARYL GLYCINAMIDE DERIVATIVES<br/>[FR] DÉRIVÉS DU 2-ARYLGLYCINAMIDE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2009137657A1
公开(公告)日:2009-11-12
The disclosure provides compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their uses in inhibiting β-amyloid peptide ( β-AP) production.